| 臺大學術典藏 |
2022-02-23T02:12:46Z |
Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: Independent and interactive effects
|
Yu M.-W.; Chiu Y.-H.; Chiang Y.-C.; CHIEN-HUNG CHEN; Lee T.-H.; Santella R.M.; Chern H.-D.; Liaw Y.-F.; Chen C.-J. |
| 臺大學術典藏 |
2022-02-23T02:12:42Z |
Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: Role of viral infection
|
Tai D.-I.; CHIEN-HUNG CHEN; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Chen Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Lin K.-C.; Changchien C.-S.; Chang W.-Y.; Sheu J.-C.; Liaw Y.-F.; Chen D.-S.; Sung J.-L. |
| 臺大學術典藏 |
2022-02-23T02:12:41Z |
Hepatitis B virus transmission and hepatocarcinogenesis: A 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma
|
CHIEN-HUNG CHEN; Chen Y.Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Lin K.-C.; Tai D.-I.; Changchien C.-S.; Chang W.-Y.; Sheu J.-C.; Chen D.-S.; Liaw Y.-F.; Sung J.-L. |
| 臺大學術典藏 |
2022-02-22T05:34:42Z |
Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: Independent and interactive effects
|
Yu M.-W.; Chiu Y.-H.; Chiang Y.-C.; CHIEN-HUNG CHEN; Lee T.-H.; Santella R.M.; Chern H.-D.; Liaw Y.-F.; Chen C.-J. |
| 臺大學術典藏 |
2022-02-22T05:34:37Z |
Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: Role of viral infection
|
Tai D.-I.; CHIEN-HUNG CHEN; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Chen Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Lin K.-C.; Changchien C.-S.; Chang W.-Y.; Sheu J.-C.; Liaw Y.-F.; Chen D.-S.; Sung J.-L. |
| 臺大學術典藏 |
2022-02-22T05:34:35Z |
Hepatitis B virus transmission and hepatocarcinogenesis: A 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma
|
CHIEN-HUNG CHEN; Chen Y.Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Lin K.-C.; Tai D.-I.; Changchien C.-S.; Chang W.-Y.; Sheu J.-C.; Chen D.-S.; Liaw Y.-F.; Sung J.-L. |
| 臺大學術典藏 |
2022-02-14T07:10:52Z |
Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B
|
Huang S.-F.; Chang I.-C.; Hong C.-C.; Yen T.-C.; Chen C.-L.; Wu C.-C.; Tsai C.-C.; Ho M.-C.; Lee W.-C.; Yu H.-C.; Shen Y.-Y.; Eng H.-L.; Wang J.; Tseng H.-H.; YUNG-MING JENG; Yeh C.-T.; Chen C.-L.; Chen P.-J.; Liaw Y.-F. |
| 臺大學術典藏 |
2022-01-25T03:25:14Z |
The Hepatitis Viral Status in Patients with Hepatocellular Carcinoma: A Study of 3843 Patients from Taiwan Liver Cancer Network
|
Chang I.-C.; Huang S.-F.; Chen P.-J.; CHI-LING CHEN; Chen C.-L.; Wu C.-C.; Tsai C.-C.; Lee P.-H.; Chen M.-F.; Lee C.-M.; Yu H.-C.; Lo G.-H.; Yeh C.-T.; Hong C.-C.; Eng H.-L.; Wang J.; Tseng H.-H.; Hsiao C.-H.; Wu H.-D.I.; Yen T.-C.; Liaw Y.-F. |
| 臺大學術典藏 |
2022-01-25T03:25:06Z |
Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B
|
Huang S.-F.; Chang I.-C.; Hong C.-C.; Yen T.-C.; CHI-LING CHEN; Wu C.-C.; Tsai C.-C.; Ho M.-C.; Lee W.-C.; Yu H.-C.; Shen Y.-Y.; Eng H.-L.; Wang J.; Tseng H.-H.; Jeng Y.-M.; Yeh C.-T.; Chen C.-L.; Chen P.-J.; Liaw Y.-F. |
| 臺大學術典藏 |
2022-01-24T09:32:31Z |
Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma
|
Yu M.-W.; Cheng S.-W.; Lin M.-W.; Yang S.-Y.; Liaw Y.-F.; Chang H.-C.; Hsiao T.-J.; Lin S.-M.; Lee S.-D.; Chen P.-J.; CHUN-JEN LIU; Chen C.-J. |
| 臺大學術典藏 |
2022-01-24T09:32:31Z |
Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives
|
Yu M.-W.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; CHUN-JEN LIU; Chen P.-J.; Hsiao T.-J.; Lee P.-H.; Chen C.-J. |
| 臺大學術典藏 |
2022-01-24T09:32:29Z |
Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan
|
Yu M.-W.; Chang H.-C.; Chen P.-J.; CHUN-JEN LIU; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Lin S.-C.; Lin C.-L.; Chen C.-J. |
| 臺大學術典藏 |
2022-01-24T09:32:28Z |
Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women
|
Yu M.-W.; Yang Y.-C.; Yang S.-Y.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU; Lee S.-D.; Lin C.-L.; Chen P.-J.; Lin S.-C.; Chen C.-J. |
| 臺大學術典藏 |
2022-01-24T09:32:27Z |
Role of Reproductive Factors in Hepatocellular Carcinoma: Impact on Hepatitis B- and C-Related Risk
|
Yu M.-W.; Chang H.-C.; Chang S.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU; Lee S.-D.; Lin C.-L.; Chen P.-J.; Lin S.-C.; Chen C.-J. |
| 臺大學術典藏 |
2022-01-24T09:32:26Z |
Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma
|
Yu M.-W.; Yang S.-Y.; Pan I.-J.; Lin C.-L.; CHUN-JEN LIU; Liaw Y.-F.; Lin S.-M.; Chen P.-J.; Lee S.-D.; Chen C.-J. |
| 臺大學術典藏 |
2022-01-24T09:32:21Z |
Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma
|
Chen C.-C.; Yang S.-Y.; CHUN-JEN LIU; Lin C.-L.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Chen C.-J.; Yu M.-W. |
| 臺大學術典藏 |
2022-01-24T09:32:20Z |
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
|
Yu M.-W.; Yeh S.-H.; Chen P.-J.; Liaw Y.-F.; Lin C.-L.; CHUN-JEN LIU; Shih W.-L.; Kao J.-H.; Chen D.-S.; Chen C.-J. |
| 臺大學術典藏 |
2022-01-24T09:32:15Z |
Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area
|
Shih W.-L.; Yu M.-W.; Chen P.-J.; Yeh S.-H.; Lo M.-T.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU; Lee S.-D.; Lin C.-L.; Hsiao C.K.; Yang S.-Y.; Chen C.-J. |
| 臺大學術典藏 |
2022-01-24T09:32:10Z |
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
|
Chou Y.-C.; Yu M.-W.; Wu C.-F.; Yang S.-Y.; Lin C.-L.; CHUN-JEN LIU; Shin W.-L.; Chen P.-J.; Liaw Y.-F.; Chen C.-J. |
| 臺大學術典藏 |
2022-01-24T09:32:02Z |
Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study
|
Shih W.-L.; Yu M.-W.; Chen P.-J.; Wu T.-W.; Lin C.-L.; CHUN-JEN LIU; Lin S.-M.; Tai D.-I.; Lee S.-D.; Liaw Y.-F. |
| 臺大學術典藏 |
2022-01-24T09:31:56Z |
Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway
|
Huang H.-H.; Shih W.-L.; Li Y.-H.; Wu C.-F.; Chen P.-J.; Lin C.-L.; CHUN-JEN LIU; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Yu M.-W. |
| 臺大學術典藏 |
2022-01-24T09:31:54Z |
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update
|
Liaw Y.-F.; Kao J.-H.; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M. |
| 臺大學術典藏 |
2022-01-24T09:31:50Z |
Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update (Hepatology International (2012) 6 (531-561) DOI: 10.1007/s12072-012-9365-4)
|
Liaw Y.-F.; Kao J.-H.; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M. |
| 臺大學術典藏 |
2022-01-24T09:31:49Z |
Influences of tobacco and alcohol use on hepatocellular carcinoma survival
|
Shih W.-L.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Chen P.-J.; CHUN-JEN LIU; Lin C.-L.; Yu M.-W. |
| 臺大學術典藏 |
2022-01-24T09:31:38Z |
Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870
|
Cheng H.-Y.; Kang P.-J.; Chuang Y.-H.; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; CHUN-JEN LIU; Liaw Y.-F.; Lin S.-M.; Chen P.-J.; Lee S.-D.; Yu M.-W. |
| 臺大學術典藏 |
2022-01-24T09:31:17Z |
Taiwan consensus statement on the management of chronic hepatitis B
|
Chien R.-N.; Kao J.-H.; Peng C.-Y.; Chen C.-H.; CHUN-JEN LIU; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; Ni Y.-H.; Chuang W.-L.; Lee C.-M.; Wu J.-C.; Chen P.-J.; Liaw Y.-F. |
| 臺大學術典藏 |
2021-09-04T06:19:04Z |
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
|
Yu M.-W.; Yeh S.-H.; Chen P.-J.; Liaw Y.-F.; Lin C.-L.; Liu C.-J.; Shih W.-L.; JIA-HORNG KAO; Chen D.-S.; Chen C.-J. |
| 臺大學術典藏 |
2021-09-04T06:19:03Z |
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2005 update
|
Liaw Y.-F.; Leung N.; Guan R.; Lau G.K.K.; Merican I.; McCaughan G.; Gane E.; JIA-HORNG KAO; Omata M.; Chutaputti B.A.; Chen D.S.; Chien R.N.; Cooksley G.; Han K.H.; Ichida T.; Lai M.Y.; Lesmana L.; Piratvisuth T.; Sarin S.K.; Sollano J.; Suh D.J.; Yao G.B.; Yeh C.T.; Yokosuka O. |
| 臺大學術典藏 |
2021-09-04T06:12:35Z |
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update
|
Liaw Y.-F.; Leung N.; JIA-HORNG KAO; Piratvisuth T.; Gane E.; Han K.-H.; Guan R.; Lau G.K.K.; Locarnini S. |
| 臺大學術典藏 |
2021-09-04T06:12:31Z |
Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update (Hepatology International 10.1007/s12072-008-9080-3)
|
Liaw Y.-F.; Leung N.; JIA-HORNG KAO; Teerha P.; Gane E.; Han K.-H.; Guan R.; Lau G.K.K.; Locarnini S. |
| 臺大學術典藏 |
2021-09-04T06:12:13Z |
Hepatitis B e antigen seroconversion: A critical event in chronic hepatitis B virus Infection
|
Liaw Y.-F.; Lau G.K.K.; JIA-HORNG KAO; Gane E. |
| 臺大學術典藏 |
2021-09-04T06:12:03Z |
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update
|
Liaw Y.-F.; JIA-HORNG KAO; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; Liu C.-J.; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M. |
| 臺大學術典藏 |
2021-09-04T06:11:59Z |
Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update (Hepatology International (2012) 6 (531-561) DOI: 10.1007/s12072-012-9365-4)
|
Liaw Y.-F.; JIA-HORNG KAO; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; Liu C.-J.; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M. |
| 臺大學術典藏 |
2021-09-04T05:17:05Z |
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B
|
Hsu C.-W.; Su W.-W.; Lee C.-M.; Peng C.-Y.; Chuang W.-L.; JIA-HORNG KAO; Chu H.-C.; Huang Y.-H.; Chien R.-N.; Liaw Y.-F. |
| 臺大學術典藏 |
2021-09-04T05:16:57Z |
Taiwan consensus statement on the management of chronic hepatitis B
|
Chien R.-N.; JIA-HORNG KAO; Peng C.-Y.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; Ni Y.-H.; Chuang W.-L.; Lee C.-M.; Wu J.-C.; Chen P.-J.; Liaw Y.-F. |
| 臺大學術典藏 |
2021-09-04T05:16:56Z |
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B
|
Wei L.; Pavlovic V.; Bansal A.T.; Chen X.; Foster G.R.; He H.; JIA-HORNG KAO; Lampertico P.; Liaw Y.-F.; Motoc A.; Papatheodoridis G.V.; Piratvisuth T.; Plesniak R.; Wat C. |
| 臺大學術典藏 |
2021-09-01T01:54:16Z |
Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma
|
Omata M.; Lesmana L.A.; Tateishi R.; Chen P.-J.; Lin S.-M.; Yoshida H.; Kudo M.; Lee J.M.; Choi B.I.; Poon R.T.P.; Shiina S.; ANN-LII CHENG; Jia J.-D.; Obi S.; Han K.H.; Jafri W.; Chow P.; Lim S.G.; Chawla Y.K.; Budihusodo U.; Gani R.A.; Lesmana C.R.; Putranto T.A.; Liaw Y.F.; Sarin S.K. |
| 臺大學術典藏 |
2021-07-03T03:35:53Z |
Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma
|
Yu M.-W.; Cheng S.-W.; Lin M.-W.; Yang S.-Y.; Liaw Y.-F.; Chang H.-C.; Hsiao T.-J.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Liu C.-J.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:53Z |
Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives
|
Yu M.-W.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Liu C.-J.; PEI-JER CHEN; Hsiao T.-J.; Lee P.-H.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:53Z |
Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: Impact of smoking on risk
|
Yu M.-W.; Pai C.-I.; Yang S.-Y.; Hsiao T.-J.; Chang H.-C.; Lin S.-M.; Liaw Y.-F.; PEI-JER CHEN; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:48Z |
Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan
|
Yu M.-W.; Chang H.-C.; PEI-JER CHEN; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Lin S.-C.; Lin C.-L.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:46Z |
Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women
|
Yu M.-W.; Yang Y.-C.; Yang S.-Y.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Liu C.-J.; Lee S.-D.; Lin C.-L.; PEI-JER CHEN; Lin S.-C.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:45Z |
Hepatitis B e antigen and the risk of hepatocellular carcinoma
|
Yang H.-I.; Lu S.-N.; Liaw Y.-F.; You S.-L.; Sun C.-A.; Wang L.-Y.; Hsiao C.K.; PEI-JER CHEN; Chen D.-S.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:41Z |
Role of Reproductive Factors in Hepatocellular Carcinoma: Impact on Hepatitis B- and C-Related Risk
|
Yu M.-W.; Chang H.-C.; Chang S.-C.; Liaw Y.-F.; Lin S.-M.; Liu C.-J.; Lee S.-D.; Lin C.-L.; PEI-JER CHEN; Lin S.-C.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:38Z |
Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma
|
Yu M.-W.; Yang S.-Y.; Pan I.-J.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN; Lee S.-D.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:26Z |
Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma
|
Chen C.-C.; Yang S.-Y.; Liu C.-J.; Lin C.-L.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Chen C.-J.; Yu M.-W. |
| 臺大學術典藏 |
2021-07-03T03:35:22Z |
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
|
Yu M.-W.; Yeh S.-H.; PEI-JER CHEN; Liaw Y.-F.; Lin C.-L.; Liu C.-J.; Shih W.-L.; Kao J.-H.; Chen D.-S.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:12Z |
Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area
|
Shih W.-L.; Yu M.-W.; PEI-JER CHEN; Yeh S.-H.; Lo M.-T.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Liu C.-J.; Lee S.-D.; Lin C.-L.; Hsiao C.K.; Yang S.-Y.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:06Z |
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
|
Chou Y.-C.; Yu M.-W.; Wu C.-F.; Yang S.-Y.; Lin C.-L.; Liu C.-J.; Shin W.-L.; PEI-JER CHEN; Liaw Y.-F.; Chen C.-J. |
| 臺大學術典藏 |
2021-07-03T03:35:04Z |
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
|
Yang H.-I.; Yeh S.-H.; PEI-JER CHEN; Iloeje U.H.; Jen C.-L.; Su J.; Wang L.-Y.; Lu S.-N.; You S.-L.; Chen D.-S.; Liaw Y.-F.; Chen C.-J. |
